Page 592 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 592

570   PART IV    Specific Malignancies in the Small Animal Patient






  VetBooks.ir



















                   A                                           B

                          • Fig. 26.2  (A) and (B) A 12-year-old female spayed domestic long-hair cat with acromegaly caused by a
                          pituitary tumor. Note the broad forehead and large mandible.

         abdominal enlargement. Owners of affected cats also frequently   was seen among well-controlled diabetic cats, poorly controlled
         note noisy or stertorous breathing or respiratory stridor. 86,87,90,91    diabetic cats, and healthy cats.  The highest IGF-1 noted in a
                                                                                        90
         A physical examination may reveal additional abnormalities, such   diabetic cat was 153 nM, with a normal reference range of 12 to
         as enlarged abdominal organs and cardiac murmurs, arrhythmias,   92 nM; thus some overlap exists between the IGF-1 values found
         or a gallop rhythm. 81,86,92  However, it also is likely that acrome-  in acromegalic cats and those found in poorly regulated diabetic
         galic cats with few physical features of the disease will be increas-  cats. However, this author’s experience (KL) is that IGF-1 levels
         ingly recognized as awareness of the disorder increases and patients   in cats with acromegaly usually are at least twice the value of the
         are diagnosed at an earlier stage. In addition, more cats may be   high end of this reference range, at least by the time the cats are
         diagnosed with acromegaly in the absence of diabetes, as has been   investigated for causes of insulin resistance. In Europe, the serum
         reported in a small number of cases ; however, the prevalence of   IGF-1 concentration typically is expressed in ng/mL, with a posi-
                                     93
                                                                                                           87
         acromegaly in the nondiabetic cat population is unknown.  tive predictive value of 95% for an IGF-1 >1000 ng/mL.  Feline
            Neurologic signs associated with the pituitary tumor generally   IGF-1 measurement is readily available to veterinarians in the
         appear to be uncommon but may be underrecognized or under-  United States, and this test should be considered for cats with
         reported. Lethargy, mental dullness, or impaired vision may occur   diabetes mellitus that appear to be insulin resistant or that have
         but often can be subtle. Affected cats also may demonstrate signs   any physical features consistent with acromegaly. 89
         of diabetic neuropathy or lameness, possibly because of acromeg-  The presence of a pituitary tumor can be demonstrated either
         aly-associated arthopathy. 81,86  An additional significant complica-  by CT or by MRI in cats with acromegaly, and both techniques
         tion of acromegaly is the development of structural and functional   have been reported in the literature. 86,96–99  MRI likely is more
                                                                              99
         cardiac disease, including increased thickness of the left ventricu-  sensitive than CT,  but both imaging modalities may reveal a
         lar wall, increased left atrial diameter, and evidence of abnormal   normal pituitary in a cat with acromegaly if the size of the mass is
         diastolic function. 94,95  Some evidence indicates that many of these   below the limit of detection. Brain imaging may also reveal bone
                                                                                                                98
         changes are reversible if the acromegaly is treated successfully. 95  or soft tissue changes that support a diagnosis of acromegaly.
            Acromegaly is the result of excessive GH secretion from a pitu-  In a case-control study of CT findings, 68 acromegalic diabetic
         itary gland tumor, and increased serum GH concentrations have   cats were compared to 36 control cats. Cats with acromegaly had
         been reported in several cats with acromegaly. Unfortunately, a   significantly thicker bones, skin, and subcutaneous tissues, and
         feline GH assay currently is not reliably available in the United   narrower nasopharynges compared to the control cats.  Addi-
                                                                                                           99
         States. The physical changes in patients with acromegaly are due   tional imaging findings supportive of acromegaly include echo-
         to the anabolic effects of GH, which are mediated by peripher-  cardiographic changes as noted previously, enlarged kidneys and
                            83
         ally synthesized IGF-1.  This hormone is produced in the liver   adrenal glands, and evidence of pancreatic changes on abdominal
         and other tissues, and serum concentrations of IGF-1 increase in   ultrasound examination. 100
         the presence of chronically increased GH production. Because   Treatment options for acromegaly in human medicine include
         GH secretion may be pulsatile, even in some acromegalics, and   surgery, conventional external-beam RT, SRT, and medical ther-
         because it has a short half-life, an increased serum IGF-1 level has   apy. Many of these therapies also have been evaluated in cats. In
         been suggested to be a more sensitive test for acromegaly because   humans, transsphenoidal surgery to remove the pituitary tumor
         it may reflect GH levels over the preceding 24 hours.  Serum   generally  is  regarded  as  the  treatment  of  choice;  however,  cur-
                                                     83
         IGF-1 values are widely reported in acromegalic cats. One study   rently only rare published reports are available on the use of sur-
         confirmed that IGF-1 measurement is a useful screening test for   gery for the treatment of feline acromegaly. 70,101,102  The largest
         feline acromegaly, with a sensitivity and specificity of 84% and   reported case series of cats undergoing hypophysectomy focused
         92%, respectively.  No difference in serum IGF-1 concentrations   on anesthetic management and complications in 37 cats with
                       90
   587   588   589   590   591   592   593   594   595   596   597